These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

399 related articles for article (PubMed ID: 12459732)

  • 21. Oncolytic gene therapy for canine cancers: teaching old dog viruses new tricks.
    Arendt M; Nasir L; Morgan IM
    Vet Comp Oncol; 2009 Sep; 7(3):153-61. PubMed ID: 19691644
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Virus combinations and chemotherapy for the treatment of human cancers.
    Kumar S; Gao L; Yeagy B; Reid T
    Curr Opin Mol Ther; 2008 Aug; 10(4):371-9. PubMed ID: 18683102
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ICP34.5 deleted herpes simplex virus with enhanced oncolytic, immune stimulating, and anti-tumour properties.
    Liu BL; Robinson M; Han ZQ; Branston RH; English C; Reay P; McGrath Y; Thomas SK; Thornton M; Bullock P; Love CA; Coffin RS
    Gene Ther; 2003 Feb; 10(4):292-303. PubMed ID: 12595888
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oncolytic herpes simplex virus vectors for cancer virotherapy.
    Varghese S; Rabkin SD
    Cancer Gene Ther; 2002 Dec; 9(12):967-78. PubMed ID: 12522436
    [TBL] [Abstract][Full Text] [Related]  

  • 25. VSV-G pseudotyped, MuLV-based, semi-replication-competent retrovirus for cancer treatment.
    Qiao J; Moreno J; Sanchez-Perez L; Kottke T; Thompson J; Caruso M; Diaz RM; Vile R
    Gene Ther; 2006 Oct; 13(20):1457-70. PubMed ID: 16724095
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oncolytic viruses for the treatment of cancer: current strategies and clinical trials.
    Ries SJ; Brandts CH
    Drug Discov Today; 2004 Sep; 9(17):759-68. PubMed ID: 15450242
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Measles as a potential oncolytic virus.
    Fielding AK
    Rev Med Virol; 2005; 15(2):135-42. PubMed ID: 15546127
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Generation of a recombinant oncolytic Newcastle disease virus and expression of a full IgG antibody from two transgenes.
    Pühler F; Willuda J; Puhlmann J; Mumberg D; Römer-Oberdörfer A; Beier R
    Gene Ther; 2008 Mar; 15(5):371-83. PubMed ID: 18200068
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A new recombinant vaccinia with targeted deletion of three viral genes: its safety and efficacy as an oncolytic virus.
    Yang S; Guo ZS; O'Malley ME; Yin X; Zeh HJ; Bartlett DL
    Gene Ther; 2007 Apr; 14(8):638-47. PubMed ID: 17268533
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oncolytic viruses for cancer therapy II. Cell-internal factors for conditional growth in neoplastic cells.
    Campbell SA; Gromeier M
    Onkologie; 2005 Apr; 28(4):209-15. PubMed ID: 15840970
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Exploiting diversity: genetic approaches to creating highly potent and efficacious oncolytic viruses.
    Bauzon M; Hermiston TW
    Curr Opin Mol Ther; 2008 Aug; 10(4):350-5. PubMed ID: 18683099
    [TBL] [Abstract][Full Text] [Related]  

  • 32. RNA viruses as virotherapy agents.
    Russell SJ
    Cancer Gene Ther; 2002 Dec; 9(12):961-6. PubMed ID: 12522435
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical trial results with oncolytic virotherapy: a century of promise, a decade of progress.
    Liu TC; Galanis E; Kirn D
    Nat Clin Pract Oncol; 2007 Feb; 4(2):101-17. PubMed ID: 17259931
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enhancing radiotherapy with genetically engineered viruses.
    Advani SJ; Weichselbaum RR; Chmura SJ
    J Clin Oncol; 2007 Sep; 25(26):4090-5. PubMed ID: 17827458
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The replication-competent oncolytic herpes simplex mutant virus NV1066 is effective in the treatment of esophageal cancer.
    Stiles BM; Bhargava A; Adusumilli PS; Stanziale SF; Kim TH; Rusch VW; Fong Y
    Surgery; 2003 Aug; 134(2):357-64. PubMed ID: 12947341
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Systemic efficacy with oncolytic virus therapeutics: clinical proof-of-concept and future directions.
    Liu TC; Kirn D
    Cancer Res; 2007 Jan; 67(2):429-32. PubMed ID: 17234747
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Oncolytic viruses for genetic therapy of gastrointestinal tumors].
    Bitzer M; Lauer UM
    Z Gastroenterol; 2003 Jul; 41(7):667-74. PubMed ID: 12858239
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oncolytic virotherapy: approaches to tumor targeting and enhancing antitumor effects.
    Thorne SH; Hermiston T; Kirn D
    Semin Oncol; 2005 Dec; 32(6):537-48. PubMed ID: 16338419
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of NF-kappaB enhances the cytotoxicity of virus-directed enzyme prodrug therapy and oncolytic adenovirus cancer gene therapy.
    Palmer DH; Chen MJ; Searle PF; Kerr DJ; Young LS
    Gene Ther; 2005 Aug; 12(15):1187-97. PubMed ID: 15800660
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multicellular tumor spheroids in gene therapy and oncolytic virus therapy.
    Lamfers ML; Hemminki A
    Curr Opin Mol Ther; 2004 Aug; 6(4):403-11. PubMed ID: 15468599
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.